Estados Unidos - inglés - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - carefully consider the potential benefits and risks of etodolac extended-release tablets, usp and other treatment options before deciding to use etodolac extended-release tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). etodolac extended-release tablets, usp are indicated: *    for relief of signs and symptoms of juvenile arthritis *    for relief of the signs and symptoms of rheumatoid arthritis *    for relief of the signs and symptoms of osteoarthritis etodolac extended-release tablets are contraindicated in patients with known hypersensitivity to etodolac. etodolac extended-release tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, preexisting asthma). etodolac extended-releas

Estados Unidos - inglés - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - carefully consider the potential benefits and risks of etodolac and other treatment options before deciding to use etodolac.  use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). etodolac capsules are indicated: • for acute and long-term use in the management of signs and symptoms of the following: - osteoarthritis - rheumatoid arthritis • for the management of acute pain etodolac is contraindicated in patients with known hypersensitivity to etodolac or other ingredients in etodolac capsules. etodolac should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions , pre-existing asthma ). - in the setting of coronary artery bypass graft (cabg) surgery (see w

Estados Unidos - inglés - NLM (National Library of Medicine)

denton pharma, inc. dba northwind pharmaceuticals - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - carefully consider the potential benefits and risks of etodolac tablets and other treatment options before deciding to use etodolac tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). etodolac tablets are indicated: - for acute and long-term use in the management of signs and symptoms of the following: - osteoarthritis - rheumatoid arthritis - for the management of acute pain etodolac is contraindicated in patients with known hypersensitivity to etodolac or other ingredients in etodolac. etodolac should not be given to patients who have experienced asthma, urticaria or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings , anaphylactoid reactions and precautions , pre-existing asthma). in the setting of coronary artery bypass graft (cabg) sur

Estados Unidos - inglés - NLM (National Library of Medicine)

st. mary's medical park pharmacy - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - carefully consider the potential benefits and risks of etodolac extended-release tablets, usp and other treatment options before deciding to use etodolac extended-release tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). etodolac extended-release tablets, usp are indicated: *    for relief of signs and symptoms of juvenile arthritis *    for relief of the signs and symptoms of rheumatoid arthritis *    for relief of the signs and symptoms of osteoarthritis etodolac extended-release tablets are contraindicated in patients with known hypersensitivity to etodolac. etodolac extended-release tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions   and

Estados Unidos - inglés - NLM (National Library of Medicine)

st. mary's medical park pharmacy - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - carefully consider the potential benefits and risks of etodolac extended-release tablets, usp and other treatment options before deciding to use etodolac extended-release tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). etodolac extended-release tablets, usp are indicated: *    for relief of signs and symptoms of juvenile arthritis *    for relief of the signs and symptoms of rheumatoid arthritis *    for relief of the signs and symptoms of osteoarthritis etodolac extended-release tablets are contraindicated in patients with known hypersensitivity to etodolac. etodolac extended-release tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions   and

Malta - inglés - Medicines Authority

2care4 aps - etodolac - film-coated tablet - etodolac 200 milligram(s) - antiinflammatory and antirheumatic products

Malta - inglés - Medicines Authority

2care4 aps - etodolac - film-coated tablet - etodolac 300 milligram(s) - antiinflammatory and antirheumatic products

Malta - inglés - Medicines Authority

2care4 generics aps stenhuggervej 12-14, 6710 esbjerg v, denmark - etodolac - film-coated tablet - etodolac 200 mg - antiinflammatory and antirheumatic products

Malta - inglés - Medicines Authority

2care4 generics aps stenhuggervej 12-14, 6710 esbjerg v, denmark - etodolac - film-coated tablet - etodolac 300 mg - antiinflammatory and antirheumatic products

Israel - inglés - Ministry of Health

teva pharmaceutical industries ltd, israel - etodolac - tablets - etodolac 400 mg - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.